Stocktoria
SpyGlass Pharma, Inc. SGP
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2026-02-06
SpyGlass Pharma, Inc. statistics & valuation
Market cap$708.1M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -34.4% | -125.1% |
| Return on equity | 40.3% | 48.2% |
| Current ratio | 12.67 | 2.23 |
Source: SEC EDGAR filings · CIK 0001778922 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.